Zacks Investment ResearchOct 15, 3:47 AM ET▼ Negative
Added to Zacks Rank #5 (Strong Sell) list with 16.7% downward revision to current year earnings consensus estimate over the last 60 days
Cerenome news
$1.71+3.64%
Close Oct 20, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral00%
Negative1100% of coverage
About Cerenome
No recent articles focused on Cerenome.
Also mentions CNSY
Articles that tag CNSY but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology